Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Review of: Jagannath VA, et al. Vitamin D for the management of multiple sclerosis. Cochrane Database Syst Rev 2018;9:10.1002/14651858.CD008422.pub3.
Key learning points
It has been proposed that vitamin D supplementation could be beneficial in people with multiple sclerosis (MS).
This updated Cochrane review found no effect of vitamin D on relapse rates, disability or changes in parameters of disease activity.
The findings should be interpreted with caution because of the small numbers of studies and low quality of evidence.
A systematic review of evidence from randomised controlled trials found no benefit for vitamin D treatment for multiple sclerosis.1
This update to a previous Cochrane review assessed evidence for the use of vitamin D in the management of MS.1 It included 12 randomised controlled trials (RCTs) with 933 participants (464 were randomised to a vitamin D group and 469 to a comparator); 11 RCTs were new to this update. Trials that tested any preparation of …
Contributors DTB Team.
Provenance and peer review Commissioned; Internally peer reviewed.